Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 31 (RPL7P31)

Target
RPL7P31
Molecular classification
Other, Pseudogene
01

Overview

Ribosomal protein L7 pseudogene 31 (RPL7P31) is classified as a **pseudogene**, specifically one of many non-functional genomic copies derived from the gene encoding ribosomal protein L7 (RPL7). Pseudogenes such as RPL7P31 do not produce functional proteins and generally do not contribute directly to biological processes, disease pathology, or serve as therapeutic targets. RPL7 is a component of the large subunit (60S) of the ribosome and is involved in protein synthesis, but processed pseudogenes like RPL7P31 typically lack coding potential and are not translated into active proteins[6][2][5]. No evidence supports a functional or biomarker role for RPL7P31, nor is it implicated as a molecular target for drugs.\n\n**Key clarifications:**\n- RPL7P31 refers to a pseudogene, not a true gene product or protein target.\n- It is not considered a therapeutic target, nor does it have known biological functions or clinical utility[6][2].\n- Its naming and classification as a pseudogene render it non-functional; therefore, selecting it as a target for therapeutic development would be inappropriate.\n- The only functional, protein-coding gene in this family is RPL7, not RPL7P31[1][3].

Other names
Ribosomal Protein L7 Pseudogene 31

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 31 (RPL7P31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 31 (RPL7P31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call